Daily Stock Analysis, CTLT, Catalent Inc, priceseries

Catalent Inc. Daily Stock Analysis
Stock Information
Open
41.06
Close
41.58
High
41.81
Low
41.06
Previous Close
41.13
Daily Price Gain
0.45
YTD High
41.81
YTD High Date
Feb 14, 2019
YTD Low
29.29
YTD Low Date
Jan 3, 2019
YTD Price Change
10.67
YTD Gain
34.52%
52 Week High
46.43
52 Week High Date
Oct 3, 2018
52 Week Low
29.23
52 Week Low Date
Dec 24, 2018
52 Week Price Change
-1.29
52 Week Gain
-3.01%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 8. 2016
24.35
Jan 9. 2017
26.53
20 Trading Days
8.96%
Link
LONG
May 9. 2017
31.51
Jun 15. 2017
36.33
26 Trading Days
15.30%
Link
LONG
Aug 28. 2017
35.36
Sep 14. 2017
40.30
12 Trading Days
13.96%
Link
LONG
Jan 19. 2018
42.94
Feb 5. 2018
45.78
11 Trading Days
6.62%
Link
LONG
Sep 12. 2018
41.90
Oct 4. 2018
44.78
16 Trading Days
6.88%
Link
Company Information
Stock Symbol
CTLT
Exchange
NYSE
Company URL
http://www.catalent.com
Company Phone
(732) 537-6200
CEO
John R. Chiminski
Headquarters
New Jersey
Business Address
14 SCHOOLHOUSE ROAD, SOMERSET, NJ 08873
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001596783
About

Catalent, Inc. is a holding company, which engages in the research, development and marketing of pharmaceutical products. It operates through the following segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. The Softgel Technologies segment engages in formulation, development and manufacturing of prescription and consumer health soft capsules, or softgels including traditional softgel capsules; and vegicaps and optishell capsules. The Drug Delivery Solutions segment includes formulation, development and manufacturing of prescription and consumer and animal health products using its proprietary optimelt, optipact, optiform and zydis technologies, other proprietary and conventional drug delivery technologies such as prefilled syringes; blow-fill seal unit dose manufacturing including its ADVASEPT technology; biologic cell line development including its GPEx and SMARTag technologies; and analytical and bioanalytical development; and testing services. The Clinical Supply Services segment includes in manufacturing, packaging, labeling, storage, distribution and inventory management for global clinical trials of drugs and biologics for customer required patient kits; fastChain demand-led clinical supply service; clinical e-solutions and informatics; and global comparator sourcing services. The company was founded in April 2007 and is headquartered in Somerset, NJ.

Description

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products worldwide. It operates through three segments: Softgel Technologies, Drug Delivery Solutions, and Clinical Supply Services. The Softgel Technologies segment provides formulation, development, and manufacturing services for softgels, which are used in a range of customer products, including prescription drugs, over-the-counter medications, dietary supplements, and unit-dose cosmetics. Its principal softgel technologies include traditional softgel capsules, and Vegicaps and OptiShell capsules. The Drug Delivery Solutions segment formulates, develops, and manufactures prescription, and consumer and animal health products using proprietary technologies, including OptiMelt, OptiPact, OptiForm, and Zydis, as well as other proprietary and conventional drug delivery technologies, such as prefilled syringes; manufactures blow-fill seal unit dose, including ADVASEPT technology; develops biologic cell line, including GPEx and SMARTag technologies; and provides analytical and bioanalytical development, and testing services, as well as offers respiratory products formulation and manufacturing, micronization and particle engineering, and regulatory consulting services. The Clinical Supply Services segment provides manufacturing, packaging, storage, distribution, and inventory management for drugs and biologics clinical trials for customer required patient kits. This segment also offers FastChain demand-led clinical supply services; clinical e-solutions and informatics; and comparator sourcing services. The company serves pharmaceutical and biotechnology companies; and consumer health companies, as well as companies in other healthcare market segments, such as animal health and medical devices, and companies in industries, including cosmetics. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.